Latest News
Setmelanotide licensed for treatment of severe obesity
New treatment for genetic obesity available in the NHS We are excited to announce patients with three genetic conditions which cause obesity (POMC, PCSK1, LEPR) can now be treated with Setmelanotide, a Melanocortin-4 receptor (MC4R) agonist in the NHS following...
Weight Stigma
Weight stigma: the role of health care professionals Commentary from Prof Rachel Batterham on this important topic. Click for articleFind MoreRecent Posts